Testing effectiveness (Phase 2)UnknownNCT06096090What this trial is testingPhase II Clinical Trial of Interleukin-2 in ADWho this might be right forAlzheimer Disease The Methodist Hospital Research Institute 40
Testing effectiveness (Phase 2)Ended earlyNCT05602727What this trial is testingEfficacy and Safety of MK-1942 as an Adjunct Therapy in Participants With Mild to Moderate Alzheimer's Disease Dementia (MK-1942-008)Who this might be right forAlzheimer's Disease Merck Sharp & Dohme LLC 99
Not applicableStudy completedNCT02205710What this trial is testingAdaptive Cognitive Training in Healthy Older AdultsWho this might be right forMild Cognitive ImpairmentMild to Moderate DementiaAlzheimer's Disease Bruyère Health Research Institute. 99
Testing effectiveness (Phase 2)Looking for participantsNCT07457125What this trial is testingThe Effect of CB-Exo-A600 in Mild to Moderate Alzheimer's DiseaseWho this might be right forMild to Moderate Alzheimer's Disease Xuanwu Hospital, Beijing 33
Early research (Phase 1)Study completedNCT02127476What this trial is testingSingle and Multiple Doses of KHK6640 in Subjects With Prodromal or Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Kyowa Kirin Co., Ltd. 57
Testing effectiveness (Phase 2)Active Not RecruitingNCT06427668What this trial is testingStudy of SPG302 in Adult Participants With Mild-to-Moderate Alzheimer's Disease (AD)Who this might be right forAlzheimer Disease Spinogenix 24
Testing effectiveness (Phase 2)WithdrawnNCT02246075What this trial is testingStudy of the Safety of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease Currently Receiving MemantineWho this might be right forAlzheimer's DiseaseDementiaCognition FORUM Pharmaceuticals Inc
Large-scale testing (Phase 3)Not Yet RecruitingNCT07191028What this trial is testingAlzheimer's Disease THErapy With NEuroaid IIWho this might be right forAlzheimer's Disease Dementia Moleac Pte Ltd. 350
Testing effectiveness (Phase 2)Study completedNCT00955409What this trial is testingLong Term Extension Study Evaluating Safety, Tolerability and Immunogenicity Of ACC-001 In Subjects With Mild To Moderate Alzheimer's DiseaseWho this might be right forAlzheimer Disease Pfizer 160
Not applicableStudy completedNCT01380288What this trial is testingCognitive Changes in Alzheimer's Disease Patients Associated With or Without White Matter Changes After RivastigmineWho this might be right forAlzheimer's Disease Dong-A University 300
Testing effectiveness (Phase 2)Study completedNCT00257673What this trial is testingSafety and Efficacy of MEM 1003 Versus Placebo in Patients With Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Memory Pharmaceuticals 183
Early research (Phase 1)Study completedNCT00633841What this trial is testingTolerability and Safety of Subcutaneous Administration of AFFITOPE AD02 in Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Affiris AG 24
Testing effectiveness (Phase 2)Study completedNCT01284387What this trial is testingAmyloid Imaging And Safety Study Of ACC-001 In Subjects With Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease JANSSEN Alzheimer Immunotherapy Research & Development, LLC 126
Testing effectiveness (Phase 2)Study completedNCT00880412What this trial is testingDetermine the Clinical Safety/Tolerability and Exploratory Efficacy of EHT 0202 as Adjunctive Therapy to Acetylcholinesterase Inhibitor in Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Exonhit 197
Testing effectiveness (Phase 2)Study completedNCT03520998What this trial is testingStudy to Assess the Safety of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer DiseaseMild to Moderate Alzheimer Disease Alkahest, Inc. 47
Testing effectiveness (Phase 2)Study completedNCT00948909What this trial is testingEfficacy and Safety Study for Subjects With Mild-to-Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease AbbVie (prior sponsor, Abbott) 274
Testing effectiveness (Phase 2)Ended earlyNCT00500500What this trial is testingEffect of EGb 761® on Patients With Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer Disease Ipsen 40
Not applicableUnknownNCT04828434What this trial is testingVirtual Individual Cognitive Stimulation Therapy: a Proof of Concept StudyWho this might be right forDementiaDementia, VascularDementia, Mixed+8 more University College, London 34
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06840054What this trial is testingThe Safety and Efficacy of Sodium Pentaborate Pentahydrate in Patients With Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer Disease Tabriz University of Medical Sciences 30
Large-scale testing (Phase 3)Ended earlyNCT04886063What this trial is testingOpen Label Study of ATH-1017 for Treatment of Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer Disease LeonaBio 423